Skip to content
Screener

Similar metrics at other companies

Titan Machinery logo
TITNU.S. — Revenue
$411.68M-9.8%
KBR logo
KBRU.S — Revenue
$1.03B-6.9%
Myriad Genetics logo
MYGNU.S. — Revenue
$187M+3.0%
FTI Consulting logo
FCNU.S. — Revenue
$596.35M+0.7%
Array Technologies, Inc. logo
ARRYU.S. — Revenue
$260.34M+61.8%
Monolithic Power Systems logo
MPWRU.S. — Revenue
$26.21M+44.6%

Other financials

Income statement

See full
Revenue$94.5M+19.3%
Gross profit$62.4M+20.5%
Operating income-$27.4M-23.4%
Net income-$26.9M-37.2%
EPS (diluted)-$0.47-34.3%

Balance sheet

See full
Cash & equivalents$11.4M-96.3%
Total debt$77.5M-2.4%
Total equity$340.1M-11.9%
Total assets$479.4M-6.6%

Cash flow

See full
Operating cash flow-$19.3M-28.0%
CapEx$3.0M+5.4%
Free cash flow-$22.2M-24.4%

Valuation

See full
Market cap$1.15B-25.9%
Enterprise value$1.21B
P/S3.4×

Profitability

See full
Gross margin64.2%0.0pp
Operating margin-33.9%+0.5pp
Net margin-32.5%+2.2pp
FCF margin-25.2%-4.6pp

Returns & leverage

See full
Return on equity-30.2%+5.2pp
Debt / equity0.2×0.0×
Current ratio6.5×-2.7×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: PROCEPT BioRobotics Corporation’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001588978-26-000030
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
System sales and leases$29,066$22,082$52,452$40,769
Handpieces and other consumables48,36843,13091,38681,141
Service5,9864,37311,6007,968
Total U.S. revenue83,42069,585155,438129,878
Outside of U.S.
System sales and leases3,4002,9457,2536,798
Handpieces and other consumables6,8286,00213,20110,479
Service8506501,7391,189

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is PROCEPT BioRobotics Corporation's U.S. — revenue?
PROCEPT BioRobotics Corporation (PRCT) reported U.S. — revenue of $83.42M in Q2 2026.
How has PROCEPT BioRobotics Corporation's U.S. — revenue changed year-over-year?
PROCEPT BioRobotics Corporation's U.S. — revenue increased by 19.9% year-over-year, from $69.59M to $83.42M.
What is the long-term trend for PROCEPT BioRobotics Corporation's U.S. — revenue?
Over 4 years (2021 to 2025), PROCEPT BioRobotics Corporation's U.S. — revenue has grown at a 74.8% compound annual growth rate (CAGR), from $28.95M to $270.38M.
What does U.S. — revenue mean?
This metric represents the total net sales generated from products and services within the United States geographic market. It serves as a primary indicator of the company's commercial adoption and market penetration for its surgical robotic systems in this specific region. Tracking this figure helps investors assess the scale of domestic operations and the effectiveness of regional sales strategies.

Ask your AI about PROCEPT BioRobotics Corporation's u.s. — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude